Taiwan Extracellular Vesicle Medical Promotion Association

台灣胞外體醫療發展協會

navigation.contact

Cell‑Therapy Breakthrough — Extracellular Vesicle Formulation Clinical Trial Begins

Taiwan Team Leads with Autologous EV Formulation Human Trial

Latest News

#Extracellular Vesicle#Cell Therapy#Clinical Trial

The autologous extracellular‑vesicle formulation promoted by our association has officially entered the human clinical‑trial phase and is expected to treat degenerative arthritis and promote tissue regeneration.

Clinical‑trial features:
• High‑purity cell sources
• Treatment‑safety monitoring
• Long‑term efficacy follow‑up

Stay tuned for updates on our research progress.

Related Articles

Book “Extracellular Vesicles and Regenerative Medicine” Officially Published

Comprehensive Analysis of EV Technologies and Clinical Development Trends

First Taiwan–Japan Extracellular Vesicle Medical Forum Concludes Successfully

Deepening International Cooperation and Sharing Innovative Applications

Taiwan Cell and Extracellular Vesicle Industry White Paper Released

Analyzing Current Industry Status and Future Development Blueprint